Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Susan Hua & Benjamin Vaughan. (2019) In vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications. International Journal of Nanomedicine 14, pages 2191-2206.
Read now
Read now
Yang Yang, Hao Li, Richard Ward, Linghuan Gao, Ji-Fu Wei & Tian-Rui Xu. (2014) Novel oxytocin receptor agonists and antagonists: a patent review (2002 – 2013). Expert Opinion on Therapeutic Patents 24:1, pages 29-46.
Read now
Read now
Jens Lyndrup & Ronald F Lamont. (2007) The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban. Expert Opinion on Investigational Drugs 16:6, pages 843-853.
Read now
Read now
Articles from other publishers (22)
Fang Hong, Guiyan He, Manqi Zhang, Boyang Yu & Chengzhi Chai. (2022) The Establishment of a Mouse Model of Recurrent Primary Dysmenorrhea. International Journal of Molecular Sciences 23:11, pages 6128.
Crossref
Crossref
Haiwen Yu, Yuting Cheng, Yiwen Lu, Wei Wu & Qiuqin Tang. 2021. Oxytocin and Health. Oxytocin and Health.
Ferdinand Althammer, Marina Eliava & Valery Grinevich. 2021. The Human Hypothalamus - Middle and Posterior Region. The Human Hypothalamus - Middle and Posterior Region
25
44
.
Maja Lozic & Mike Ludwig. 2021. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology
1203
1209
.
Maja Lozic & Mike Ludwig. 2020. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology
1
7
.
Chengzhi Chai, Fang Hong, Yan Yan, Lu Yang, Hui Zong, Changsong Wang, Zhigang Liu & Boyang Yu. (2020) Effect of traditional Chinese medicine formula GeGen decoction on primary dysmenorrhea: A randomized controlled trial study. Journal of Ethnopharmacology 261, pages 113053.
Crossref
Crossref
Isao Kii, Shino Hirahara-Owada, Masataka Yamaguchi, Takashi Niwa, Yuka Koike, Rie Sonamoto, Harumi Ito, Kayo Takahashi, Chihiro Yokoyama, Takuya Hayashi, Takamitsu Hosoya & Yasuyoshi Watanabe. (2018) Quantification of receptor activation by oxytocin and vasopressin in endocytosis-coupled bioluminescence reduction assay using nanoKAZ. Analytical Biochemistry 549, pages 174-183.
Crossref
Crossref
C. Sue Carter. (2017) The Oxytocin–Vasopressin Pathway in the Context of Love and Fear. Frontiers in Endocrinology 8.
Crossref
Crossref
G. Leng & J. A. Russell. (2016) The Peptide Oxytocin Antagonist F-792, When Given Systemically, Does Not Act Centrally in Lactating Rats. Journal of Neuroendocrinology 28:4.
Crossref
Crossref
Lu YANG, Zhengyu CAO, Boyang YU & Chengzhi CHAI. (2015) An <i>in vivo</i> mouse model of primary dysmenorrhea. Experimental Animals 64:3, pages 295-303.
Crossref
Crossref
Lin-Chien Lee, Cheng-Hao Tu, Li-Fen Chen, Horng-Der Shen, Hsiang-Tai Chao, Ming-Wei Lin & Jen-Chuen Hsieh. (2014) Association of Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism with Primary Dysmenorrhea. PLoS ONE 9:11, pages e112766.
Crossref
Crossref
James Olcese & Stephen Beesley. (2014) Clinical significance of melatonin receptors in the human myometrium. Fertility and Sterility 102:2, pages 329-335.
Crossref
Crossref
S. Arrowsmith & S. Wray. (2014) Oxytocin: Its Mechanism of Action and Receptor Signalling in the Myometrium. Journal of Neuroendocrinology 26:6, pages 356-369.
Crossref
Crossref
Sun-Wei Guo, Xiaoyan Mao, Qingliang Ma & Xishi Liu. (2013) Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis. Fertility and Sterility 99:1, pages 231-240.
Crossref
Crossref
M. Manning, A. Misicka, A. Olma, K. Bankowski, S. Stoev, B. Chini, T. Durroux, B. Mouillac, M. Corbani & G. Guillon. (2012) Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics. Journal of Neuroendocrinology 24:4, pages 609-628.
Crossref
Crossref
Cedric Viero, Izumi Shibuya, Naoki Kitamura, Alexei Verkhratsky, Hiroaki Fujihara, Akiko Katoh, Yoichi Ueta, Hans H. Zingg, Alexandr Chvatal, Eva Sykova & Govindan Dayanithi. (2010) REVIEW: Oxytocin: Crossing the Bridge between Basic Science and Pharmacotherapy. CNS Neuroscience & Therapeutics 16:5, pages e138-e156.
Crossref
Crossref
Vassiliki Magafa, Lenka Borovičková, Jiřina Slaninová & Paul Cordopatis. (2009) Synthesis and biological activity of oxytocin analogues containing unnatural amino acids in position 9: structure activity study. Amino Acids 38:5, pages 1549-1559.
Crossref
Crossref
Steven Thornton, Thomas M. Goodwin, Gorm Greisen, Morten Hedegaard & Joan-Carles Arce. (2009) The effect of barusiban, a selective oxytocin antagonist, in threatened preterm labor at late gestational age: a randomized, double-blind, placebo-controlled trial. American Journal of Obstetrics and Gynecology 200:6, pages 627.e1-627.e10.
Crossref
Crossref
Francesca Conti, Sarah Sertic, Alessandra Reversi & Bice Chini. (2009) Intracellular trafficking of the human oxytocin receptor: evidence of receptor recycling via a Rab4/Rab5 “short cycle”. American Journal of Physiology-Endocrinology and Metabolism 296:3, pages E532-E542.
Crossref
Crossref
Ronald F. Lamont. (2008) Oxytocin Receptor Antagonists for Inhibiting Preterm Labour. Obstetrics & Gynecology 111:1, pages 218.
Crossref
Crossref
James Sharkey & James Olcese. (2007) Transcriptional Inhibition of Oxytocin Receptor Expression in Human Myometrial Cells by Melatonin Involves Protein Kinase C Signaling. The Journal of Clinical Endocrinology & Metabolism 92:10, pages 4015-4019.
Crossref
Crossref
Mariana Gabriela Farina, Silvia Billi, Gustavo Leguizamón, Carina Weissmann, Tamara Guadagnoli, Maria Laura Ribeiro & Ana Maria Franchi. (2007) Secretory and cytosolic phospholipase A2 activities and expression are regulated by oxytocin and estradiol during labor. Reproduction 134:2, pages 355-364.
Crossref
Crossref